Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 368

1.

Inherited human IFNγ deficiency underlies mycobacterial disease.

Kerner G, Rosain J, Guérin A, AlKhabaz A, Oleaga-Quintas C, Rapaport F, Massaad MJ, Ding JY, Khan T, Al Ali F, Rahman M, Deswarte C, Martinez-Barricarte R, Geha RS, Jeanne-Julien V, Garcia DST, Chi CY, Yang R, Roynard M, Fleckenstein B, Rozenberg F, Boisson-Dupuis S, Ku CL, Seeleuthner Y, Beziat V, Marr N, Abel L, Al-Herz W, Casanova JL, Bustamante J.

J Clin Invest. 2020 Mar 12. pii: 135460. doi: 10.1172/JCI135460. [Epub ahead of print]

2.

The societal economic burden of autosomal dominant polycystic kidney disease in the United States.

Cloutier M, Manceur AM, Guerin A, Aigbogun MS, Oberdhan D, Gauthier-Loiselle M.

BMC Health Serv Res. 2020 Feb 18;20(1):126. doi: 10.1186/s12913-020-4974-4.

3.

Optimal Design of Multilayer Fog Collectors.

Azeem M, Guérin A, Dumais T, Caminos L, Goldstein RE, Pesci AI, de Dios Rivera J, Torres MJ, Wiener J, Campos JL, Dumais J.

ACS Appl Mater Interfaces. 2020 Feb 12;12(6):7736-7743. doi: 10.1021/acsami.9b19727. Epub 2020 Jan 30.

PMID:
31945290
4.

Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research.

Guerin AA, Bonomo Y, Lawrence AJ, Baune BT, Nestler EJ, Rossell SL, Kim JH.

Front Psychiatry. 2019 Dec 17;10:880. doi: 10.3389/fpsyt.2019.00880. eCollection 2019. Review.

5.

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review.

Mohr P, Kiecker F, Soriano V, Dereure O, Mujika K, Saiag P, Utikal J, Koneru R, Robert C, Cuadros F, Chacón M, Villarroel RU, Najjar YG, Kottschade L, Couselo EM, Koruth R, Guérin A, Burne R, Ionescu-Ittu R, Perrinjaquet M, Zager JS.

Melanoma Manag. 2019 Oct 4;6(4):MMT33. doi: 10.2217/mmt-2019-0015.

6.

Exome sequencing identifies de novo splicing variant in XRCC6 in sporadic case of autism.

Sjaarda CP, Wood S, McNaughton AJM, Taylor S, Hudson ML, Liu X, Guerin A, Ayub M.

J Hum Genet. 2020 Mar;65(3):287-296. doi: 10.1038/s10038-019-0707-0. Epub 2019 Dec 12.

PMID:
31827253
7.

Institutionalization risk and costs associated with agitation in Alzheimer's disease.

Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guerin A, Hartry A, Baker RA, Duffy R, Gwin K, Sanon Aigbogun M.

Alzheimers Dement (N Y). 2019 Nov 23;5:851-861. doi: 10.1016/j.trci.2019.10.004. eCollection 2019.

8.

Comparison of burnout, anxiety and depressive syndromes in hospital psychiatrists and other physicians: Results from the ESTEM study.

Hardy P, Costemale-Lacoste JF, Trichard C, Butlen-Ducuing F, Devouge I, Cerboneschi V, Jacob E, Buferne R, Benyamina A, Cantero A, Gravier V, Ghanem T, Guérin A, Meidinger A, Baleyte JM, Pelissolo A, Corruble E.

Psychiatry Res. 2020 Feb;284:112662. doi: 10.1016/j.psychres.2019.112662. Epub 2019 Oct 30.

PMID:
31703985
9.

Response to: Alfred Sandrock, Wildon Farwell. Letter to the Editor, Comparisons Between Separately Conducted Clinical Trials: Letter to the Editor Regarding Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, et al. Adv Ther (2019) 36(5):1164-76. doi:10.1007/s12325-019-00923-8.

Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, Pivneva I, Wu EQ, Arjunji R, Feltner D, Sproule DM.

Adv Ther. 2019 Nov;36(11):2982-2985. doi: 10.1007/s12325-019-01088-0. Epub 2019 Sep 11. No abstract available.

10.

Detection of rock bridges by infrared thermal imaging and modeling.

Guerin A, Jaboyedoff M, Collins BD, Derron MH, Stock GM, Matasci B, Boesiger M, Lefeuvre C, Podladchikov YY.

Sci Rep. 2019 Sep 11;9(1):13138. doi: 10.1038/s41598-019-49336-1.

11.

Second-line rituximab-bendamustine versus rituximab-gemcitabine-oxaliplatin in diffuse large B-cell lymphoma in the real world.

Ionescu-Ittu R, Shang A, Velde NV, Guerin A, Lin Y, Shi L, Shi S, Qayum N.

J Comp Eff Res. 2019 Oct;8(13):1067-1075. doi: 10.2217/cer-2019-0062. Epub 2019 Aug 27.

12.

Effect of saw blade geometry on crack initiation and propagation on the lateral cortical hinge for HTO: Finite element analysis.

Ehlinger M, Ollivier M, Course S, Guerin A, Lantz É, Zahraa D, Bonnomet F, Bahlouli N.

Orthop Traumatol Surg Res. 2019 Oct;105(6):1079-1083. doi: 10.1016/j.otsr.2019.04.026. Epub 2019 Aug 22.

PMID:
31447398
13.

Secondary tricuspid regurgitation: Do we understand what we would like to treat?

Guérin A, Dreyfus J, Le Tourneau T, Sportouch C, Lairez O, Eicher JC, Flécher E, Réant P, Donal E.

Arch Cardiovasc Dis. 2019 Oct;112(10):642-651. doi: 10.1016/j.acvd.2019.04.010. Epub 2019 Jul 24. Review.

PMID:
31351805
14.

Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in pregnancy: Considerations for management and review of the literature.

Ho B, MacKenzie J, Walia J, Geraghty M, Smith G, Nedvidek J, Guerin A.

JIMD Rep. 2019 Mar 14;46(1):28-34. doi: 10.1002/jmd2.12025. eCollection 2019 Mar.

15.

A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon.

Oleaga-Quintas C, Deswarte C, Moncada-Vélez M, Metin A, Krishna Rao I, Kanık-Yüksek S, Nieto-Patlán A, Guérin A, Gülhan B, Murthy S, Özkaya-Parlakay A, Abel L, Martínez-Barricarte R, Pérez de Diego R, Boisson-Dupuis S, Kong XF, Casanova JL, Bustamante J.

Hum Mol Genet. 2018 Nov 15;27(22):3919-3935. doi: 10.1093/hmg/ddy275. Erratum in: Hum Mol Genet. 2019 Feb 1;28(3):524.

16.

Impact of temperature and oxygen on the fate of Bacillus weihenstephanensis in a food-based medium.

Guérin A, Dargaignaratz C, Clavel T, Broussolle V, Nguyen-The C.

Food Microbiol. 2019 Oct;83:175-180. doi: 10.1016/j.fm.2019.05.011. Epub 2019 May 25.

PMID:
31202409
17.

Economic burden of relapse/recurrence in patients with major depressive disorder.

Gauthier G, Mucha L, Shi S, Guerin A.

J Drug Assess. 2019 May 24;8(1):97-103. doi: 10.1080/21556660.2019.1612410. eCollection 2019.

18.

Caffey Disease.

Guerin A, Dupuis L, Mendoza-Londono R.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
2012 Aug 2 [updated 2019 Jun 13].

19.

Uplift of an elastic membrane by a viscous flow.

Berhanu M, Guérin A, Courrech du Pont S, Raoult F, Perrier R, Michaut C.

Phys Rev E. 2019 Apr;99(4-1):043102. doi: 10.1103/PhysRevE.99.043102.

PMID:
31108581
20.

Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration.

Vander Velde N, Guerin A, Ionescu-Ittu R, Shi S, Wu EQ, Lin SW, Hsu LI, Saum KU, de Ducla S, Wang J, Li S, Thåström A, Liu S, Shi L, Leppert JT.

Eur Urol Oncol. 2019 Feb;2(1):12-20. doi: 10.1016/j.euo.2018.07.003. Epub 2018 Aug 4.

PMID:
30929841
21.

Pain and gastrointestinal dysfunction are significant associations with psychiatric disorders in patients with Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective study.

Wasim S, Suddaby JS, Parikh M, Leylachian S, Ho B, Guerin A, So J.

Rheumatol Int. 2019 Jul;39(7):1241-1248. doi: 10.1007/s00296-019-04293-w. Epub 2019 Mar 28.

PMID:
30923956
22.

Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1.

Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, Pivneva I, Wu EQ, Arjunji R, Feltner D, Sproule DM.

Adv Ther. 2019 May;36(5):1164-1176. doi: 10.1007/s12325-019-00923-8. Epub 2019 Mar 16.

23.

Drug Shortages in Canada and Selected European Countries: A Cross-Sectional, Institution-Level Comparison.

Videau M, Chemali L, Stucki C, Saavedra-Mitjans M, Largana S, Guerin A, Bonnabry P, Delhauteur B, Van Hees T, Lebel D, Bussières JF.

Can J Hosp Pharm. 2019 Jan-Feb;72(1):7-15. Epub 2018 Feb 28.

24.

Dry eye disease ranking among common reasons for seeking eye care in a large US claims database.

Bradley JL, Özer Stillman I, Pivneva I, Guerin A, Evans AM, Dana R.

Clin Ophthalmol. 2019 Feb 1;13:225-232. doi: 10.2147/OPTH.S188314. eCollection 2019.

25.

Mini-review: effect sizes and meta-analysis for antifouling research.

Guerin AJ, Clare AS.

Biofouling. 2018 Nov;34(10):1185-1199. doi: 10.1080/08927014.2018.1550196. Epub 2019 Feb 13. Review.

PMID:
30760037
26.

Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System.

Dana R, Bradley JL, Guerin A, Pivneva I, Stillman IÖ, Evans AM, Schaumberg DA.

Am J Ophthalmol. 2019 Jun;202:47-54. doi: 10.1016/j.ajo.2019.01.026. Epub 2019 Feb 2.

27.

Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective.

Ritchie EK, Latremouille-Viau D, Guerin A, Pivneva I, Habucky K, Ndife B, Joseph GJ, Atallah EL.

Leuk Lymphoma. 2019 Jun;60(6):1476-1484. doi: 10.1080/10428194.2018.1538510. Epub 2019 Jan 22.

PMID:
30668234
28.

How the new European data protection regulation affects clinical research and recommendations?

Demotes-Mainard J, Cornu C, Guérin A; participants of Giens XXXIV Round Table “Clinical research”.

Therapie. 2019 Feb;74(1):31-42. doi: 10.1016/j.therap.2018.12.004. Epub 2018 Dec 20.

PMID:
30642661
29.

Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome.

Lacy B, Ayyagari R, Guerin A, Lopez A, Shi S, Luo M.

Therap Adv Gastroenterol. 2019 Jan 1;12:1756284818818326. doi: 10.1177/1756284818818326. eCollection 2019.

30.

Quel impact du nouveau règlement européen sur la protection des données sur la recherche clinique et recommandations.

Demotes-Mainard J, Cornu C, Guérin A; les participants à la table ronde « Recherche clinique » des Ateliers de Giens XXXIV.

Therapie. 2019 Feb;74(1):17-29. doi: 10.1016/j.therap.2018.11.008. Epub 2018 Nov 30. French. No abstract available.

31.

Hospital pharmacy technicians practice and perceptions in France and Quebec, Canada.

Roland C, Guérin A, Vaconsin P, Bussières JF.

Int J Pharm Pract. 2019 Jun;27(3):271-278. doi: 10.1111/ijpp.12500. Epub 2018 Dec 11.

PMID:
30537431
32.

Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based Analysis

Wu JJ, Armstrong A, Singh R, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Arikan D, Fleischer A, Guérin A, Ganguli A.

J Drugs Dermatol. 2018 Nov 1;17(11):1211-1218.

PMID:
30500143
33.

Roles and Impacts of the Transplant Pharmacist: A Systematic Review.

Sam S, Guérin A, Rieutord A, Belaiche S, Bussières JF.

Can J Hosp Pharm. 2018 Sep-Oct;71(5):324-337. Epub 2018 Oct 31. Review.

34.

Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States.

Stein E, Xie J, Duchesneau E, Bhattacharyya S, Vudumula U, Ndife B, Bonifacio G, Guerin A, Li N, Joseph G.

Pharmacoeconomics. 2019 Feb;37(2):239-253. doi: 10.1007/s40273-018-0732-4.

PMID:
30382485
35.

[The impact of POP (Publish Or Perish) culture on pharmaceutical journals].

Guérin A, Astier A.

Ann Pharm Fr. 2018 Nov;76(6):419-420. doi: 10.1016/j.pharma.2018.10.001. French. No abstract available.

PMID:
30342568
36.

Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial.

Dahyot-Fizelier C, Frasca D, Lasocki S, Asehnoune K, Balayn D, Guerin AL, Perrigault PF, Geeraerts T, Seguin P, Rozec B, Elaroussi D, Cottenceau V, Guyonnaud C, Mimoz O; PROPHY-VAP Study group, ATLANREA group.

BMJ Open. 2018 Oct 18;8(10):e021488. doi: 10.1136/bmjopen-2018-021488.

37.

A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon.

Oleaga-Quintas C, Deswarte C, Moncada-Vélez M, Metin A, Krishna Rao I, Kanik-Yüksek S, Nieto-Patlán A, Guérin A, Gülhan B, Murthy S, Özkaya-Parlakay A, Abel L, Martínez-Barricarte R, Pérez de Diego R, Boisson-Dupuis S, Kong XF, Casanova JL, Bustamante J.

Hum Mol Genet. 2019 Feb 1;28(3):524. doi: 10.1093/hmg/ddy357. No abstract available.

38.

Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study.

Dana R, Bradley JL, Guerin A, Pivneva I, Evans AM, Stillman IÖ.

Am J Ophthalmol. 2019 Feb;198:181-192. doi: 10.1016/j.ajo.2018.10.001. Epub 2018 Oct 9.

39.

The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis.

Kimball AB, Sundaram M, Gauthier G, Guérin A, Pivneva I, Singh R, Ganguli A.

Dermatol Ther (Heidelb). 2018 Dec;8(4):557-569. doi: 10.1007/s13555-018-0264-z. Epub 2018 Oct 10.

40.

Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States.

Stein EM, Yang M, Guerin A, Gao W, Galebach P, Xiang CQ, Bhattacharyya S, Bonifacio G, Joseph GJ.

Health Qual Life Outcomes. 2018 Sep 21;16(1):193. doi: 10.1186/s12955-018-1013-9.

41.

A real-world analysis of healthcare costs and relative risk of hyperprolactinemia associated with antipsychotic treatments in the United States.

Cloutier M, Greene M, Touya M, Gagnon-Sanschagrin P, Guerin A.

J Med Econ. 2018 Dec;21(12):1183-1190. doi: 10.1080/13696998.2018.1521415. Epub 2018 Sep 26.

PMID:
30188234
42.

Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States.

Seiter K, Latremouille-Viau D, Guerin A, Ndife B, Habucky K, Tang DH, Pivneva I, Gagnon-Sanschagrin P, Joseph GJ.

Adv Ther. 2018 Oct;35(10):1671-1685. doi: 10.1007/s12325-018-0772-3. Epub 2018 Aug 28.

PMID:
30155792
43.

Treatment and Monitoring Patterns Among Premenopausal Women with HR+/HER2- Advanced Breast Cancer.

Dalal AA, Gauthier G, Gagnon-Sanschagrin P, Burne R, Guérin A, Niravath P, Small T.

Adv Ther. 2018 Sep;35(9):1356-1367. doi: 10.1007/s12325-018-0764-3. Epub 2018 Aug 13.

PMID:
30105655
44.

Toxoplasma gondii chromosomal passenger complex is essential for the organization of a functional mitotic spindle: a prerequisite for productive endodyogeny.

Berry L, Chen CT, Francia ME, Guerin A, Graindorge A, Saliou JM, Grandmougin M, Wein S, Bechara C, Morlon-Guyot J, Bordat Y, Gubbels MJ, Lebrun M, Dubremetz JF, Daher W.

Cell Mol Life Sci. 2018 Dec;75(23):4417-4443. doi: 10.1007/s00018-018-2889-6. Epub 2018 Jul 26.

45.

Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2- Metastatic Breast Cancer.

Guérin A, Goldschmidt D, Small T, Gagnon-Sanschagrin P, Romdhani H, Gauthier G, Kelkar S, Wu EQ, Niravath P, Dalal AA.

Adv Ther. 2018 Aug;35(8):1251-1264. doi: 10.1007/s12325-018-0740-y. Epub 2018 Jun 26.

PMID:
29946797
46.

A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.

Béziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, Pellier I, Zoghi S, Baris S, Keles S, Gray P, Du N, Wang Y, Zerbib Y, Lévy R, Leclercq T, About F, Lim AI, Rao G, Payne K, Pelham SJ, Avery DT, Deenick EK, Pillay B, Chou J, Guery R, Belkadi A, Guérin A, Migaud M, Rattina V, Ailal F, Benhsaien I, Bouaziz M, Habib T, Chaussabel D, Marr N, El-Benna J, Grimbacher B, Wargon O, Bustamante J, Boisson B, Müller-Fleckenstein I, Fleckenstein B, Chandesris MO, Titeux M, Fraitag S, Alyanakian MA, Leruez-Ville M, Picard C, Meyts I, Di Santo JP, Hovnanian A, Somer A, Ozen A, Rezaei N, Chatila TA, Abel L, Leonard WJ, Tangye SG, Puel A, Casanova JL.

Sci Immunol. 2018 Jun 15;3(24). pii: eaat4956. doi: 10.1126/sciimmunol.aat4956.

47.

Dosing Patterns and Economic Burden of Palbociclib Drug Wastage in HR+/HER2- Metastatic Breast Cancer.

Dalal AA, Gagnon-Sanschagrin P, Burne R, Guérin A, Gauthier G, Small T, Niravath P.

Adv Ther. 2018 Jun;35(6):768-778. doi: 10.1007/s12325-018-0701-5. Epub 2018 Jun 4.

PMID:
29869106
48.

Drag-reducing riblets with fouling-release properties: development and testing.

Benschop HOG, Guerin AJ, Brinkmann A, Dale ML, Finnie AA, Breugem WP, Clare AS, Stübing D, Price C, Reynolds KJ.

Biofouling. 2018 May;34(5):532-544. doi: 10.1080/08927014.2018.1469747. Epub 2018 May 28.

PMID:
29806493
49.
50.

Reimbursement landscape for molecular testing in non-small cell lung cancer (NSCLC).

Nellesen D, Dea K, Guerin A, Culver KW, Mutebi A, Dalal A.

Am J Manag Care. 2018 Feb;24(2 Spec No.):SP37-SP42. Review. No abstract available.

Supplemental Content

Loading ...
Support Center